116
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Chylothorax, central venous thrombosis and pulmonary infarct in a patient of ovarian germ cell tumor: a case report

      Published
      case-report
      Bookmark

            Abstract

            Background:

            Extra-abdominal presentations are rarely seen in ovarian germ cell tumors (OGCT). We report a case of a patient with OGCT who presented with systemic venous thrombosis, pulmonary infarct, and chylothorax simultaneously.

            Case Presentation:

            A 13-year-old girl presented with dyspnea, fever, and cough of 1 week duration. She was detected to have left-sided chylothorax. Carcinoma Antigen 125 and alpha fetoprotein levels were raised. Computed tomography showed a large ovarian mass, and thrombi in superior vena cava, left brachiocephalic vein, and segmental branch of right pulmonary artery. She also had a peripheral opacity in the right lung with a reverse-halo sign, suggestive of pulmonary infarct. She was diagnosed with yolk-sac tumor and managed with anticoagulation and subsequently neo-adjuvant chemotherapy and surgery.

            Conclusion:

            Prothrombotic state in OGCT can lead to systemic thrombosis which may result in chylothorax due to obstruction of thoracic duct. The phenomenon, though rare, should be kept in mind during management of OGCT.

            Main article text

            Background

            Ovarian germ cell tumors (OGCTs) are the second most common ovarian neoplasms, after surface epithelial tumors, and represent 70% of ovarian neoplasms in young, adolescent females [1]. Ovarian tumors may cause increase in thrombogenesis because of tumor-derived interleukin-6, tissue-factor expression, thrombocytosis, direct compression of pelvic veins, and several other postulated mechanisms [2]. Systemic thrombosis, often reported with surface epithelial tumors of ovary is uncommonly reported in OGCTs [3]. Similarly, chylothorax, commonly associated with lymphoproliferative malignancies, is rare in ovarian malignancies [3,4].

            We report a case of OGCT that developed systemic thrombosis, pulmonary infarct, and chylothorax simultaneously and was successfully managed with chemotherapy and anticoagulation.

            Case Presentation

            A 13-year-old girl presented with complaints of fever, dry cough, and progressive shortness of breath of 7 days duration. There was no history of chest pain, palpitations, or syncope. She had also been symptomatic with menorrhagia and dysmenorrhea for the preceding 6 months.

            On examination, she had fever with a maximum recorded temperature of 38.3°C, tachycardia (heart rate 134 per minute), tachypnoea (respiratory rate 28 per minute), and oxygen saturation of 88% (in ambient air by pulse oximetry). Blood pressure was normal. She had facial puffiness and neck veins were engorged (Figure 1). On systemic examination, decreased left sided chest movements with dullness on percussion and decreased air entry in left infra-axillary and infra-scapular regions were noted. There was fullness in the abdomen with a palpable abdomino-pelvic mass.

            On further evaluation, she had anemia (hemoglobin 8.8 g/dl) and leucocytosis (total leucocyte count 16,800 cells per mm3 with neutrophils of 80%). Her liver function and renal function tests were normal. Work-up for common endemic tropical infections (dengue, malaria, enteric fever, and scrub typhus) and coronavirus disease 2019 was negative. D-dimer level was raised at 1,741 ng/ml.

            Chest radiograph showed left sided pleural effusion (Figure 2). Thoracentesis was performed and 300 ml pleural fluid was drained which was milky white in appearance. Analysis of the pleural fluid revealed an exudative character with 95% lymphocytes, and elevated levels of lactate dehydrogenase (480 U/l) and triglyceride (930 mg/dl) while serum triglyceride level was 133 mg/dl. Adenosine dehydrogenase level was normal. Staining and culture of pleural fluid were negative for infection.

            Figure 1.

            Image showing engorged neck veins and facial puffiness at presentation.

            Figure 2.

            Chest radiograph showing left-sided pleural effusion.

            Figure 3.

            CT scan images showing the large solid-cystic ovarian tumor (asterix), left-sided pleural effusion and minimal right-sided effusion, thrombosis of SVC and left brachiocephalic vein (thin arrows) with multiple collaterals in thorax and mediastinum (curved arrows), pulmonary artery thrombus (thick arrow) and pulmonary infarct in right lower lobe showing reverse-halo sign (double-arrow).

            Ultrasonography and subsequently contrast-enhanced computed tomography (CECT) scan of thorax, abdomen, and pelvis (Figure 3) showed an abdomino-pelvic solid cystic lesion, likely ovarian in origin with right hydroureteronephrosis. There was thrombosis of superior vena cava (SVC) and left brachiocephalic vein, along with thrombus in segmental branch of right pulmonary artery. Lower lobe of the right lung showed a peripheral opacity with central ground-glass haze and a surrounding dense rim of consolidation [reverse-halo sign (RHS) or atoll sign] that was interpreted as pulmonary infarct. Left-sided pleural effusion along with a small right-sided pleural effusion was seen. There was no evidence of pelvic vein or inferior vena cava thrombosis.

            Carcinoma antigen 125 was raised at 350 IU/ml and alpha-fetoprotein at 2,873 ng/ml while beta human chorionic gonadotropin level was normal.

            A diagnosis of ovarian yolk-sac tumor with chylothorax, SVC thrombosis and pulmonary embolism was made. Contrast-enhanced magnetic resonance imaging of abdomen was suggestive of a large well-defined, smooth-marginated, oval solid-cystic lesion in lower abdomen and pelvis, predominantly left sided and extending across midline, measuring 10 × 16 × 20 cm with cystic areas within lesion. Few foci of blooming were noted within the lesion, causing displacement of bowel loops to the right.

            Since the patient had no central line insertion or any other obvious etiology for SVC thrombosis, the possibility of ovarian neoplasia related procoagulant state leading to SVC thrombosis was kept. Either an embolus from here or an in-situ thrombosis in the segmental branch of right pulmonary artery might have led to the pulmonary infarct. Thus, the thrombosis of SVC and left brachiocephalic vein leading to central venous hypertension, could have resulted in chyle leak from thoracic duct.

            She was managed with anticoagulation for SVC and pulmonary artery thrombosis. In view of hypoxia, pulmonary infarction, and SVC thrombosis, she was considered medically inoperable after a multi-disciplinary discussion. She was started on chemotherapy with bleomycin, etoposide, and cisplatin.

            Her general condition improved with chemotherapy and pleural effusion had regressed completely. Repeat CECT showed resolution of thrombosis and significant regression in the size of the ovarian mass. After three cycles of chemotherapy, she underwent interval debulking surgery involving left salpingo-oophorectomy with infra-colic omentectomy and multiple peritoneal biopsies.

            Pathological specimen showed left ovarian mass with no residual tumor in the resected specimen or omental biopsy (chemotherapy response score 3- complete pathological response). She received one more cycle of adjuvant chemotherapy after surgery and is currently in remission.

            Discussion

            This patient was diagnosed as OGCT with venous thromboembolism and chylothorax. Prothrombotic state has been commonly associated with surface epithelial tumors of ovary, but rarely with OGCTs [2,3,5]. We inferred that the patient developed a thrombosis of SVC and left brachiocephalic vein, due to underlying prothrombotic state. RHS on CT chest, in presence of thrombus in pulmonary artery was suggestive of pulmonary infarct [6].

            Thoracic duct usually joins the venous system at the junction between left internal jugular vein and left subclavian vein (formation of left brachiocephalic vein). Thrombosis of left brachiocephalic vein or SVC, as in our case, would increase central venous pressure leading to chyle leak and chylothorax. The phenomenon, although rare, has been described in pediatric [7-9] as well as adult age group [3,10-13].

            Chylothorax has previously been described with ovarian tumors and rarely with OGCT. Etonyeaku et al. [14] described a case of chylothorax and chylous ascites in a case of bilateral primary Burkitt’s lymphoma of the ovaries. Gupta et al. [15] also reported a case of sex cord stromal tumor of ovary that developed left sided chylothorax after oophorectomy. Katwal et al. [3] presented a case of OGCT with bilateral chylothorax and central vein thrombosis, like our case. The authors suggested that mediastinal lymphadenopathy along with the hypercoagulable state due to malignancy led to central vein thrombosis. Thus, the blockade led obstruction to the flow of thoracic duct, resulting in chylothorax.

            Our patient had a large left-sided chylothorax, with a small right-sided effusion and no ascites. There were no significant nodes. In the absence of ascites, subdiaphragmatic lymphatic duct obstruction by the tumor was not a likely cause of chylothorax. Thus, the most probable explanation for chylothorax in our patient is central venous thrombosis. Conversely, chylothorax leading to a hypercoagulable state and venous thrombosis, due to loss of antithrombin in chyle, has also been suggested.

            Conclusion

            The case highlights that OGCT in young females can present as a prothrombotic state with central venous thrombosis. Thrombosis of SVC or left brachiocephalic vein can lead to central venous hypertension resulting in chyle leak from the thoracic duct. The case also underscores pulmonary infarct as an important differential of a solitary peripheral pulmonary lesion presenting with RHS. This report exemplifies application of “Occam’s razor” in Medicine - different varying aspects of clinical presentation are usually linked together, and a unified simplistic explanation should always be attempted.

            What is new?

            Chylothorax has previously been described with ovarian tumors and rarely with OGCT. Katwal et al. [3] presented a case of OGCT with bilateral chylothorax and central vein thrombosis, like this case. The case highlights that OGCT in young females can present as a prothrombotic state with central venous thrombosis. Thrombosis of SVC or left brachiocephalic vein can lead to central venous hypertension resulting in chyle leak from the thoracic duct. The case also underscores pulmonary infarct as an important differential of a solitary peripheral pulmonary lesion presenting with RHS.

            List of Abbreviations

            CECTContrast enhanced CT scan for chest
            OGCTOvarian germ cell tumor
            RHSReverse-halo sign
            SVCSuperior vena cava

            Conflict of interest

            None of the authors declare any conflict of interest regarding the publication of this article.

            Funding

            None.

            Consent for publication

            Written and informed consent was taken from patient to publish this case report.

            Ethical approval

            Ethical approval to publish an anonymous case report has been waivered at our institution.

            References

            1. Euscher ED. Germ cell tumors of the female genital tract. Surg Pathol Clin. 2019. Vol. 12(2):621–49. [Cross Ref]

            2. Hisada Y, Mackman N. Cancer-associated pathways and biomarkers of venous thrombosis. Blood. 2017. Vol. 130(13):1499–506. [Cross Ref]

            3. Katwal P, Rai S, Mukherjee S, Ghosh P, Ghosh J, Bhaumik J. Germ cell tumour of the ovary presenting with chylothorax and central vein thrombosis: a case report. Indian J Gynecol Oncol. 2020. Vol. 18(1):32[Cross Ref]

            4. Gupta R, Bal A, Das A, Kumar Marwah R. Serous cystadenocarcinoma of the ovary in an 11-year-old girl with extensive dissemination and chylothorax: a case report and a brief review of literature. J Pediatr Hematol Oncol. 2009. Vol. 31(7):533–5. [Cross Ref]

            5. Hoskote SS, Yadav H, Jagtap P, Wigle DA, Daniels CE. Chylothorax as a risk factor for thrombosis in adults: a proof-of-concept study. Ann Thorac Surg. 2018. Vol. 105(4):1065–70. [Cross Ref]

            6. Mançano AD, Rodrigues RS, Barreto MM, Zanetti G, Moraes TC, Marchiori E. Incidence and morphological characteristics of the reversed halo sign in patients with acute pulmonary embolism and pulmonary infarction undergoing computed tomography angiography of the pulmonary arteries. J Bras Pneumol. 2019. Vol. 45(1):e20170438[Cross Ref]

            7. Berkenbosch JW, Monteleone PM, Tobias JD. Chylothorax following apparently spontaneous central venous thrombosis in a patient with septic shock. Pediatr Pulmonol. 2003. Vol. 35(3):230–3. [Cross Ref]

            8. Poswal L, Dhyani A, Malik P, Ameta P. Bilateral chylothorax due to brachiocephalic vein thrombosis in relapsing nephrotic syndrome. Indian J Pediatr. 2015. Vol. 82(12):1181–2. [Cross Ref]

            9. Rathore V, Bhattacharya D, Pandey J, Bhatia A, Dawman L, Tiewsoh K. Chylothorax in a child with nephrotic syndrome. Indian J Nephrol. 2020. Vol. 30(1):32–4. [Cross Ref]

            10. Austin A, Al-Faris F, Modi A, Chopra A. A transudative chylothorax associated with superior vena cava syndrome. Respir Med Case Rep. 2019. Vol. 28:100898[Cross Ref]

            11. Kho SS, Tie ST, Chan SK, Yong MC, Chai SL, Voon PJ. Chylothorax and central vein thrombosis, an under-recognized association: a case series. Respirol Case Rep. 2017. Vol. 5(3):e00221[Cross Ref]

            12. Tacoronte Pérez S, Cerón Navarro J, Pastor Colom A, Morcillo Aixelá A. Chylothorax due to venous thrombosis in a double-lung transplant patient. Arch Bronconeumol (Engl Ed). 2019. Vol. 55(7):381–2. [Cross Ref]

            13. Thomas R, Christopher DJ, Roy A, Rose A, Chandy ST, Cherian RA, et al.. Chylothorax following innominate vein thrombosis - a rare complication of transvenous pacemaker implantation. Respiration. 2007. Vol. 74(3):338–40. [Cross Ref]

            14. Etonyeaku AC, Akinsanya OO, Ariyibi O, Aiyeyemi AJ. Chylothorax from bilateral primary Burkitt’s lymphoma of the ovaries: a case report. Case Rep Obstet Gynecol. 2012. Vol. 2012:635121[Cross Ref]

            15. Gupta PR, Taly A, Joshi N, Gupta S, Meena RC, Jain S. Chylothorax in a patient with ovarian tumour. Indian J Chest Dis Allied Sci. 2005. Vol. 47(1):43–6

            Summary of the case

            1 Patient (gender, age) Female, 13 years old
            2 Final diagnosis
            1. OGCT

            2. Venous thromboembolism

            3. Chylothorax

            3 Symptoms Fever, dry cough, and progressive shortness of breath.
            4 Medications
            1. Anticoagulation for SVC and pulmonary artery thrombosis.

            2. Chemotherapy with bleomycin, etoposide and cisplatin.

            5 Clinical procedure
            1. Chest radiograph, ultrasonography, CECT scan.

            2. Left salpingo-oophorectomy with infra-colic omentectomy.

            3. Multiple peritoneal biopsies.

            6 Specialty Internal medicine, pulmonology and oncology

            Author and article information

            Journal
            European Journal of Medical Case Reports
            EJMCR
            Discover STM Publishing Ltd.
            2520-4998
            30 April 2023
            : 7
            : 4
            : 79-82
            Affiliations
            [1 ]Department of Internal Medicine, Army Hospital (Research & Referral), Delhi, India
            [2 ]Department of Pulmonary Medicine, Army Hospital (Research & Referral), Delhi, India
            [3 ]Department of Oncology, Army Hospital (Research & Referral), Delhi, India
            Author notes
            [* ] Correspondence to: Itishree Singh Department of Pulmonology, Army Hospital (Research & Referral), Delhi, India. itishreesingh94@ 123456gmail.com
            Article
            ejmcr-7-79
            10.24911/ejmcr/173-1654111988
            cae0337e-299c-40cd-8c67-075b4fb8bd03
            © Abhishek Sharma, Itishree Singh, Sarvinder Singh, Anvesh Rathore, Puneet Saxena, Anuradha Ahuja

            This is an open access article distributed in accordance with the Creative Commons Attribution (CC BY 4.0) license: https://creativecommons.org/licenses/by/4.0/) which permits any use, Share — copy and redistribute the material in any medium or format, Adapt — remix, transform, and build upon the material for any purpose, as long as the authors and the original source are properly cited.

            History
            : 01 June 2022
            : 08 February 2023
            Categories
            CASE REPORT

            reverse-halo sign,pulmonary infarct,chylothorax,Ovarian germ cell tumor,case report,yolk-sac tumor,systemic thrombosis

            Comments

            Comment on this article